These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36861326)

  • 1. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
    Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
    J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
    Sauter J; Turner D; Briken P; Rettenberger M
    Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses.
    Sauter J; Lingenti LM; Rettenberger M; Turner D; Briken P; Voß T
    Dialogues Clin Neurosci; 2024; 26(1):28-37. PubMed ID: 38837043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Change or Stop Testosterone-Lowering Medication (COSTLow) Scale Using the Delphi Method Among Clinical Experts.
    Briken P; Turner D; Thibaut F; Bradford J; Cosyns P; Tozdan S
    J Sex Marital Ther; 2019; 45(2):148-158. PubMed ID: 30040595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Dekker A; Briken P
    World J Biol Psychiatry; 2014 Aug; 15(6):472-8. PubMed ID: 24219802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal and Policy Implications in Mexico of Changes in ICD-11 Paraphilic Disorders.
    Martínez-López JNI; Robles R; Fresán A; Montis IA; Kismödi E; Medina-Mora ME; Reed GM
    J Sex Med; 2019 Oct; 16(10):1623-1637. PubMed ID: 31515198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, controlled, clinical trial planned in germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders: presentation of the study protocol.
    Briken P; Berner W;
    Isr J Psychiatry Relat Sci; 2012; 49(4):306-13. PubMed ID: 23585468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-psychopathy men with a history of sexual offending have protective factors too: But are these risk relevant and can they change in treatment?
    Olver ME; Riemer EK
    J Consult Clin Psychol; 2021 May; 89(5):406-420. PubMed ID: 33829820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To Reoffend or Not to Reoffend? An Investigation of Recidivism Among Individuals With Sexual Offense Histories and Psychopathy.
    Leung PC; Looman J; Abracen J
    Sex Abuse; 2021 Feb; 33(1):88-113. PubMed ID: 31538857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Legal Situation for Patients with Paraphilic disorders and Implications of the ICD-11 for Paraphilic Disorders for Germany.
    Briken P; Boetticher A; Krueger RB; Kismödi E; Reed GM
    J Sex Med; 2019 Oct; 16(10):1615-1622. PubMed ID: 31447381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraphilias, Sociodemographic and Forensic Profiles of Men Convicted of Sexual Offenses in Turkey.
    Kok Kendirlioglu B; Ipekcioglu D; Havle N; Ilnem MC
    Sex Abuse; 2024 Feb; 36(1):59-75. PubMed ID: 37635404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal and Policy Considerations in Lebanon Related to Proposals for Paraphilic Disorders in World Health Organization's International Classification of Diseases Manual, 11th Version.
    Makhlouf Y; Kerbage H; Khauli N; Ramadan Z; Khoury B
    J Sex Med; 2020 Mar; 17(3):491-504. PubMed ID: 31953030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting sexual and nonsexual recidivism in a consecutive sample of juveniles convicted of sexual offences.
    Aebi M; Plattner B; Steinhausen HC; Bessler C
    Sex Abuse; 2011 Dec; 23(4):456-73. PubMed ID: 21406605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathy and treatment outcome: Results from a sexual violence reduction program.
    Sewall LA; Olver ME
    Personal Disord; 2019 Jan; 10(1):59-69. PubMed ID: 29927298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forensic Implications of the New Classification of ICD-11 Paraphilic Disorders in Brazil.
    Abdalla-Filho E; de Jesus Mari J; Diehl A; Vieira DL; Ribeiro RB; Marins de Moraes T; Reed GM; Kismodi E; Cordeiro Q
    J Sex Med; 2019 Nov; 16(11):1814-1819. PubMed ID: 31551191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Psychopathic Traits in the Development of the Therapeutic Alliance Among Sexual Offenders.
    Walton A; Jeglic EL; Blasko BL
    Sex Abuse; 2018 Apr; 30(3):211-229. PubMed ID: 27000265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.